Literature DB >> 7978647

Hepatic total 3 alpha-hydroxy bile acids concentration and enzyme activities in prednisone-treated dogs.

P F Solter1, W E Hoffmann, M D Chambers, D J Schaeffer, M S Kuhlenschmidt.   

Abstract

High serum alkaline phosphatase (ALP) activity is considered a sensitive marker of cholestasis in most mammalian species, including dogs. Induction of high serum ALP activity in association with cholestasis is dependent on high hepatic bile acids concentrations. Treatment of dogs with glucocorticoids also results in high serum ALP activity. The possible causal relation between serum ALP activity and bile acids concentration was investigated in dogs treated with glucocorticoids. The relation of glucocorticoid treatment to changes in the activity of individual ALP isoenzymes, alanine transaminase (ALT) and gamma-glutamyltransferase (GGT) also was investigated. Eight conditioned dogs were given 4 mg of prednisone/kg of body weight, i.m., daily for 10 days. Blood samples were taken prior to treatment and on treatment days 3, 5, 7, and 10. Liver tissue was then taken from each dog. Serum total ALP activity was significantly (P < 0.05) high at day 3 in prednisone-treated dogs. Isoenzyme analysis indicated that this increase was attributable to an increase in the liver ALP isoenzyme (LALP). Significant increases in serum corticosteroid-induced ALP (CALP) and bone ALP were first observed on days 7 and 10, respectively. Serum ALT and GGT activities were significantly increased by day 5. Increased serum or hepatic tissue bile acids concentrations were not observed in prednisone-treated dogs, compared with values in 8 clinically normal (control) dogs, but were high in 3 dogs with complete bile duct ligation. Hepatic activities of LALP, CALP, and GGT were higher in prednisone-treated dogs than values in controls, indicating probable increased hepatic synthesis of these enzymes. Hepatic ALT activity was not increased.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7978647

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy.

Authors:  G Elizabeth Pluhar; Patrick T Grogan; Charlie Seiler; Michelle Goulart; Karen S Santacruz; Cathy Carlson; Wei Chen; Mike R Olin; Pedro R Lowenstein; Maria G Castro; Stephen J Haines; John R Ohlfest
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

2.  Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

Authors:  J H Burton; R O Venable; D M Vail; L E Williams; C A Clifford; S M Axiak-Bechtel; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2015-06-25       Impact factor: 3.333

3.  Incidence of hepatopathies in dogs administered zonisamide orally: A retrospective study of 384 cases.

Authors:  Tess K Smith; Starr Cameron; Lauren A Trepanier
Journal:  J Vet Intern Med       Date:  2022-03-02       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.